Mechanisms of progressive renal disease: Role of angiotensin II, cyclooxygenase products and nitric oxide

Journal of Hypertension

Volumn 20, Issue SUPPL. 3, 2002, Pages

  Zatz, Roberto ^a   Fujihara, Clarice Kazue ^a  

^a Laboratorio de Fisiopatologia Renal   (Brazil)

Author keywords

Angiotensin II; Chronic renal failure; Cyclooxygenase; Inflammation; Nitric oxide; Prostaglandins

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; ANGIOTENSIN II; RENIN;

ARTHRITIS; CELL INFILTRATION; CELL PROLIFERATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; GLOMERULOPATHY; HEMODYNAMICS; HOMEOSTASIS; HUMAN; INFLAMMATION; KIDNEY DISEASE; KIDNEY FIBROSIS; MACROPHAGE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; CYTOLOGY; GLOMERULUS; IMMUNOLOGY; MESANGIUM; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANIMALS; ENDOTHELIUM, VASCULAR; GLOMERULAR MESANGIUM; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY GLOMERULUS; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RENIN;

EID: 0036600418     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (96)

1. Role of CD8(+) cells in the progression of murine adriamycin nephropathy
2. Nephron adaptation to renal injury or ablation
3. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney
4. Increased glomerular capillary pressure alters glomerular cytokine expression
5. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics, and metabolic activity
6. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat
7. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis
8. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy
9. Provoost AR From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: A histopathological study in rat models and human glomerulopathies
10. Mesangial function and glomerular sclerosis in rats after unilateral nephrectomy
11. Glomerular hyalinosis and its relation to hyperfiltration
12. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation
13. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model
14. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
15. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
16. Cellular events in the evolution of experimental diabetic nephropathy
17. Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia
18. Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model
19. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome
20. Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals
21. Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney
22. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney
23. Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat
24. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells
25. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor
26. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis
27. Angiotensin II acts as a T cell cytokine in alloimmune responses
28. Angiotensin II stimulates extra-cellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells
29. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro
30. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
31. Effects of candesartan cilexetil on oxidative state and renal function in 5/6 nephrectomized rats
32. Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats
33. Enhanced interstitial expression of angiotensin II and TGF beta in the renal ablation model: Effect of mycophenolate mofetil
34. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
35. Differential expression of myofibroblasts and angiotensin II in chronic vs. acute allograft rejection biopsies
36. Concomitant treatment with losartan (L) and an anti-inflammatory arrests renal injury in rats with 5/6 renal ablation (Nx)
37. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass
38. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension
39. Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial
40. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
41. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
42. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
43. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
44. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
45. Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti-inflammatory therapy
46. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis
47. Upregulation of cyclooxy-genase-1 and the PGE(2) receptor EP2 in rat and human mesangioproliferative glomerulonephritis
48. Upregulation of juxta-glomerular NOS1 and COX-2 precedes glomerulosclerosis in fawn-hooded hypertensive rats
49. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis
50. Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells: Role of cyclooxygenase- 1 and -2
51. Selective increase of cyclooxygenase-2 expression in a model of renal ablation
52. Enhanced glomerular prostaglandin formation in experimental membranous nephropathy
53. Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells
54. PGF2alpha-induced signaling events in glomerular mesangial cells
55. Effects of prostaglandin E2 on mesangial cell migration
56. Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons
57. Mechanical stretch/relaxation of cultured rat mesangial cells induces protooncogenes and cyclooxygenase
58. Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney
59. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
60. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis
61. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation
62. Antiproteinuric effect of a thromboxane receptor antagonist, S-1452, on rat diabetic nephropathy and murine lupus nephritis
63. A thromboxane synthetase antagonist ameliorates progressive renal disease of Dahl-S rats
64. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney
65. Effects of acute nitric oxide inhibition on rat glomerular microcirculation
66. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage
67. Sodium excess aggravates hypertension and renal parenchymal iniury in rats with chronic NO inhibition
68. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy
69. Renal and systemic nitric oxide synthesis in rats with renal mass reduction
70. Total nitric oxide production is low in patients with chronic renal disease
71. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production
72. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model
73. L-Arginine-nitric oxide pathway and chronic nephropathy in aged rats
74. Short term nitric oxide inhibition predisposes to the development of progressive nephropathy
75. Induction of nitric oxide synthase in rat immune complex glomerulonephritis
76. Role of nitric oxide in rat nephrotoxic nephritis: Comparison between inducible and constitutive nitric oxide synthase
77. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat
78. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients
79. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis
80. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation
81. Aminoguanidine ameliorates renal injury in the renal ablation model
82. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine
83. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat
84. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation
85. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
86. Nitric oxide donors induce apoptosis in glomerular mesangial cells, epithelial cells and endothelial cells
87. Nitric oxide activates cyclooxygenase enzymes
88. Glomerular adaptations to chronic dietary salt restriction or excess
89. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries
90. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotension II
91. Angiotensin II-induced myocardial fibrosis in rats: Role of nitric oxide, prostaglandins and bradykinin
92. Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo
93. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
94. Induction of cyclooxygenase-2 on activated T lymphocytes: Regulation of T cell activation by cyclooxygenase-2 inhibitors
95. Altered immune responses in mice lacking inducible nitric oxide synthase